- VIVUS Announces Date of Second Quarter 2014 Update and Financial Results Conference Call
- VIVUS Files Lawsuit Against Actavis for Infringement of Qsymia Patents
- VIVUS to Present at Upcoming Investor Conference
- Avanafil Clinical Data to Be Presented at American Urological Association
- VIVUS Announces Qsymia Presentation at the American Association of Clinical Endocrinologists (AACE)
A Growing Pipeline
VIVUS is developing innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health.